N Grois

Summary

Affiliation: St. Anna Children's Hospital
Country: Austria

Publications

  1. ncbi request reprint Neuropathology of CNS disease in Langerhans cell histiocytosis
    Nicole Grois
    Langerhans Cell Histiocytosis Study Reference Center, Children Cancer Research Institute, St Anna Children s Hospital, Kinderspitalgasse 6, A 1090 Vienna, Austria
    Brain 128:829-38. 2005
  2. ncbi request reprint Risk factors for diabetes insipidus in langerhans cell histiocytosis
    N Grois
    Children s Cancer Research Institute, Vienna, Austria
    Pediatr Blood Cancer 46:228-33. 2006
  3. ncbi request reprint Pineal gland abnormalities in Langerhans cell histiocytosis
    N Grois
    Children s Cancer Research Institute, St Anna Children s Hospital, Vienna, Austria
    Pediatr Blood Cancer 43:261-6. 2004
  4. ncbi request reprint Cyclosporine A therapy for multisystem langerhans cell histiocytosis
    M Minkov
    St Anna Children s Hospital, Vienna, Austria
    Med Pediatr Oncol 33:482-5. 1999
  5. ncbi request reprint Long-term MR imaging course of neurodegenerative Langerhans cell histiocytosis
    H Prosch
    Department of Radiology, Otto Wagner Hospital, Vienna, Austria
    AJNR Am J Neuroradiol 28:1022-8. 2007
  6. ncbi request reprint A randomized trial of treatment for multisystem Langerhans' cell histiocytosis
    H Gadner
    St Anna Children's Hospital, Vienna, Austria
    J Pediatr 138:728-34. 2001
  7. ncbi request reprint Langerhans cell histiocytosis in neonates
    M Minkov
    St Anna Children s Hospital, Vienna, Austria
    Pediatr Blood Cancer 45:802-7. 2005
  8. ncbi request reprint Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-study
    C Titgemeyer
    St. Anna Children's Hospital, Kinderspitalgasse 6, A-1090 Vienna, Austria
    Med Pediatr Oncol 37:108-14. 2001
  9. ncbi request reprint Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning
    M Steiner
    1St Anna Children s Hospital, Vienna, Austria
    Bone Marrow Transplant 36:215-25. 2005
  10. doi request reprint Reactivations in multisystem Langerhans cell histiocytosis: data of the international LCH registry
    Milen Minkov
    St Anna Children s Hospital, Vienna, Austria
    J Pediatr 153:700-5, 705.e1-2. 2008

Collaborators

Detail Information

Publications23

  1. ncbi request reprint Neuropathology of CNS disease in Langerhans cell histiocytosis
    Nicole Grois
    Langerhans Cell Histiocytosis Study Reference Center, Children Cancer Research Institute, St Anna Children s Hospital, Kinderspitalgasse 6, A 1090 Vienna, Austria
    Brain 128:829-38. 2005
    ....
  2. ncbi request reprint Risk factors for diabetes insipidus in langerhans cell histiocytosis
    N Grois
    Children s Cancer Research Institute, Vienna, Austria
    Pediatr Blood Cancer 46:228-33. 2006
    ..In an attempt to define the population at risk for DI, 1,741 patients with LCH registered on the trials DALHX 83 and DALHX 90, LCH I and LCH II were studied...
  3. ncbi request reprint Pineal gland abnormalities in Langerhans cell histiocytosis
    N Grois
    Children s Cancer Research Institute, St Anna Children s Hospital, Vienna, Austria
    Pediatr Blood Cancer 43:261-6. 2004
    ..In the review process of magnetic resonance images (MRI) from 129 LCH patients a high frequency of cysts within or large pineal glands was noted by chance...
  4. ncbi request reprint Cyclosporine A therapy for multisystem langerhans cell histiocytosis
    M Minkov
    St Anna Children s Hospital, Vienna, Austria
    Med Pediatr Oncol 33:482-5. 1999
    ..Treatment of multisystem Langerhans cell histiocytosis (LCH) remains difficult. Various regimens of single and multiagent chemotherapy have been used, but a significant proportion of patients fail to respond to treatment...
  5. ncbi request reprint Long-term MR imaging course of neurodegenerative Langerhans cell histiocytosis
    H Prosch
    Department of Radiology, Otto Wagner Hospital, Vienna, Austria
    AJNR Am J Neuroradiol 28:1022-8. 2007
    ..The purpose of this study was to describe the long-term course of MR imaging signal intensity abnormalities in ND-LCH on T1- and T2-weighted images...
  6. ncbi request reprint A randomized trial of treatment for multisystem Langerhans' cell histiocytosis
    H Gadner
    St Anna Children's Hospital, Vienna, Austria
    J Pediatr 138:728-34. 2001
    ....
  7. ncbi request reprint Langerhans cell histiocytosis in neonates
    M Minkov
    St Anna Children s Hospital, Vienna, Austria
    Pediatr Blood Cancer 45:802-7. 2005
    ..To study the incidence, clinical patterns, course, and outcome of neonatal Langerhans cell histiocytosis (LCH)...
  8. ncbi request reprint Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-study
    C Titgemeyer
    St. Anna Children's Hospital, Kinderspitalgasse 6, A-1090 Vienna, Austria
    Med Pediatr Oncol 37:108-14. 2001
    ..However, reactivations had an impact on morbidity, as permanent consequences were mostly related to the site of disease activity. Med Pediatr Oncol 2001;37:108-114...
  9. ncbi request reprint Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning
    M Steiner
    1St Anna Children s Hospital, Vienna, Austria
    Bone Marrow Transplant 36:215-25. 2005
    ..Based on this observation, we conclude that RIC-SCT is a feasible procedure with low transplant-related morbidity and mortality and a promising new salvage approach for high-risk LCH patients with resistant risk organ involvement...
  10. doi request reprint Reactivations in multisystem Langerhans cell histiocytosis: data of the international LCH registry
    Milen Minkov
    St Anna Children s Hospital, Vienna, Austria
    J Pediatr 153:700-5, 705.e1-2. 2008
    ..To assess multisystem Langerhans cell histiocytosis reactivation and its impact on morbidity and mortality...
  11. ncbi request reprint Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification
    Helmut Gadner
    Children s Cancer Research Institute, St Anna Children s Hospital, Vienna, Austria
    Blood 111:2556-62. 2008
    ..042). We conclude that intensified treatment significantly increases rapid response and reduces mortality in risk MS-LCH. This trial was registered at http://www.controlled-trials.com as no. ISRCTN57679341...
  12. doi request reprint Pattern and course of neurodegeneration in Langerhans cell histiocytosis
    Martha Wnorowski
    St Anna Children Hospital, Vienna, Austria
    J Pediatr 153:127-32. 2008
    ..To explore the frequency and course of neurodegenerative central nervous system (CNS) disease in Langerhans cell histiocytosis (ND-LCH)...
  13. ncbi request reprint Immunosuppressive treatment for chemotherapy-resistant multisystem Langerhans cell histiocytosis
    Milen Minkov
    CCRI, St Anna Children s Hospital, Vienna, Austria
    Med Pediatr Oncol 40:253-6. 2003
  14. ncbi request reprint Course and clinical impact of magnetic resonance imaging findings in diabetes insipidus associated with Langerhans cell histiocytosis
    Nicole Grois
    Children s Cancer Research Institute, Vienna, Austria
    Pediatr Blood Cancer 43:59-65. 2004
    ..The clinical relevance and therapeutic impact of brain magnetic resonance imaging (MRI) findings in LCH patients with LCH during the disease course is unclear...
  15. ncbi request reprint Central diabetes insipidus: Is it Langerhans cell histiocytosis of the pituitary stalk? A diagnostic pitfall
    Helmut Prosch
    Children s Cancer Research Institute, Vienna, Austria
    Pediatr Blood Cancer 46:363-6. 2006
    ..This case underscores the importance of a istopathologically proven diagnosis in patients with HPR tumors before the initiation of a specific therapy, even if the clinical findings are highly suggestive...
  16. ncbi request reprint Central diabetes insipidus as presenting symptom of Langerhans cell histiocytosis
    Helmut Prosch
    Children s Cancer Research Institute, Vienna, Austria
    Pediatr Blood Cancer 43:594-9. 2004
    ..If possible, this histopathological proof should be provided by a biopsy of extracranial lesions to avoid a potentially hazardous biopsy of the pituitary stalk...
  17. ncbi request reprint Bone marrow assessment in Langerhans cell histiocytosis
    Milen Minkov
    St Anna Children s Hospital, Vienna, Austria
    Pediatr Blood Cancer 49:694-8. 2007
    ..The aim of the present study was to characterize the bone marrow changes in LCH patients and to ascertain their relation to disease severity...
  18. ncbi request reprint Central nervous system-related permanent consequences in patients with Langerhans cell histiocytosis
    Edda Mittheisz
    Children s Cancer Research Institute, Vienna, Austria
    Pediatr Blood Cancer 48:50-6. 2007
    ..The frequency and pattern of permanent consequences affecting the central nervous system (CNS) remains to be determined...
  19. ncbi request reprint Modern imaging methods for the assessment of Langerhans' cell histiocytosis-associated neurodegenerative syndrome: case report
    Manuel Steiner
    Children s Cancer Research Institute, Vienna, Austria
    J Child Neurol 20:253-7. 2005
    ..In particular, magnetic resonance spectroscopy could provide a valuable diagnostic tool in addition to MRI in the early detection and evaluation of the neurodegenerative component of this disease...
  20. ncbi request reprint MR imaging presentation of intracranial disease associated with Langerhans cell histiocytosis
    Daniela Prayer
    Department of Neuroradiology, University Clinic of Radiodiagnostics, Vienna, Austria
    AJNR Am J Neuroradiol 25:880-91. 2004
    ..Intracranial manifestations of Langerhans cell histiocytosis (LCH) are underestimated in frequency and diversity. We categorized the spectrum of MR imaging changes in LCH...
  21. ncbi request reprint Demonstration of CD1a positive cells in the cerebrospinal fluid--A clue to diagnosis of isolated Langerhans cell histiocytosis of the hypothalamic-pituitary axis?
    Helmut Prosch
    Children s Cancer Research Institute, Vienna, Austria
    Med Pediatr Oncol 41:474-6. 2003
  22. ncbi request reprint Normal monocyte-derived dendritic cell function in patients with Langerhans-cell-histiocytosis
    Wolfgang Holter
    CCRI, St Anna Children s Hospital, Vienna, Austria
    Med Pediatr Oncol 39:181-6. 2002
    ..The cause of this disease is unknown. Langerhans cells are bone marrow-derived dendritic cells (DCs), which can develop from CD34(+) hematopoietic progenitor cells as well as from monocytes...
  23. ncbi request reprint Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator
    Milen Minkov
    St Anna Children s Hospital, Kinderspitalgasse 9, A 1090 Vienna, Austria
    Med Pediatr Oncol 39:581-5. 2002
    ..Furthermore, we compare the predictive value of response to initial therapy to some other well-established stratification systems...